See All Slides - tctmd.com

Slides

Presentation The Structural Heart Disease Summit 2018

The INTREPID Program: Attributes, Challenges, and Clinical Data (FDA Pivotal RCT APOLLO)

Presenter: Vinayak Bapat

June 22, 2018

Presentation The Structural Heart Disease Summit 2018

When Should the Tricuspid Valve Be Repaired During Mitral Valve Surgery?

Presenter: Georg Nickenig, Stephan Windecker, Steven F. Bolling

June 22, 2018

Presentation The Structural Heart Disease Summit 2018

Percutaneous Tricuspid Edge-to-Edge Repair With Novel Multi-Plane Transjugular Echocardiography

Presenter: Isaac George, Christopher U. Meduri, Austin Robnson, MD

June 22, 2018

Presentation The Structural Heart Disease Summit 2018

TR Due to Pacemaker Lead Entrapment: Frequency, Diagnosis, Clinical Consequencs, and Treatment Alternatives

Presenter: Georg Nickenig, Stephan Windecker, Neil P. Fam

June 22, 2018

Presentation The Structural Heart Disease Summit 2018

Interventional Perspectives of TMVR: Addressing the Four Big Questions

Presenter: Martin B. Leon, Gregg W. Stone

June 22, 2018

Presentation The Structural Heart Disease Summit 2018

Transcatheter Valve-in-Valve Replacement of the Systemic AV (Tricuspid) Valve in D-Loop Transposition of the Great Arteries With Atrial Switch

Presenter: Isaac George, Christopher U. Meduri, Tiffany Chen, MD

June 22, 2018

Presentation The Structural Heart Disease Summit 2018

Medical Therapy for TR and Indications (Thresholds) for Surgical/Transcatheter Therapies

Presenter: Georg Nickenig, Stephan Windecker, Ori Ben-Yehuda

June 22, 2018

Presentation The Structural Heart Disease Summit 2018

Surgical Perspectives of TMVR: Focus on Patient Selection and Clinical Management Issues

Presenter: Martin B. Leon, Gregg W. Stone, Michael J. Mack

June 22, 2018

Presentation The Structural Heart Disease Summit 2018

Will the Randomized Trials of MitraClip in Secondary MR Show Substantial Clinical Benefit? YES!

Presenter: Scott Lim

June 22, 2018

Presentation The Structural Heart Disease Summit 2018

Will the Randomized Trials of MitraClip in Secondary MR Show Substantial Clinical Benefit? NO!

Presenter: Francesco Maisano

June 22, 2018

Advertisement

Slides

The INTREPID Program: Attributes, Challenges, and Clinical Data (FDA Pivotal RCT APOLLO)

When Should the Tricuspid Valve Be Repaired During Mitral Valve Surgery?

Percutaneous Tricuspid Edge-to-Edge Repair With Novel Multi-Plane Transjugular Echocardiography

TR Due to Pacemaker Lead Entrapment: Frequency, Diagnosis, Clinical Consequencs, and Treatment Alternatives

Interventional Perspectives of TMVR: Addressing the Four Big Questions

Transcatheter Valve-in-Valve Replacement of the Systemic AV (Tricuspid) Valve in D-Loop Transposition of the Great Arteries With Atrial Switch

Medical Therapy for TR and Indications (Thresholds) for Surgical/Transcatheter Therapies

Surgical Perspectives of TMVR: Focus on Patient Selection and Clinical Management Issues

Will the Randomized Trials of MitraClip in Secondary MR Show Substantial Clinical Benefit? YES!

Will the Randomized Trials of MitraClip in Secondary MR Show Substantial Clinical Benefit? NO!

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content